April 4, 2022 (Kawasaki, Japan) - Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida et al. presented their research results about ...

UTRECHT, The Netherlands--(BUSINESS WIRE)--Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced that it has closed a EUR 15 ...

Protein-based drugs must be transported into cells in a way that prevents their immediate degradation. A new approach is intended to ensure that they remain intact only in certain cells, such as ...

BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal ...

The latest short science news items from C&EN. A complicated sequence of events follows once an RNA drug is injected into the body. After the lipid-packaged RNA arrives at a cell, it pushes through ...

Macromolecules such as peptides, proteins and siRNAs show great promise as therapeutic agents in precision medicine, but their large size complicates delivery into the cytoplasm or nucleus. Adding ...

A study recently published in the Journal of Cell Biology has demonstrated the endosomal transport process of nanoparticle-based formulations that leads to the effective delivery of messenger ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station. Thanks to international ...

RNA-based drugs have been slow to realize their therapeutic promise because they often find themselves trapped in endosomes and delivered to degradative lysosomes. Yet if RNA-based drugs could be ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) and Entrada Therapeutics Inc. (TRDA) have established collaboration to discover and develop endosomal escape vehicle therapeutics for Myotonic Dystrophy ...